PTEN could inhibit pancreatic cancer progression through suppressing PI3K/AKT and NF-κB signal pathways [26, 27] and was targeted by different miRNAs in pancreatic cancer [28, 29]. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.